Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00705406Phase 2Completed
A Phase 2 trial of peramivir in influenza, sponsored by BioCryst Pharmaceuticals, Inc.. Started Jul 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00705406.